New Sucampo Amitiza launch squeezes $10m milestone out of Takeda
This article was originally published in Scrip
Executive Summary
Maryland, US-based biopharmaceutical company, Sucampo Pharmaceuticals has received a $10m milestone payment from its collaborative partner, Takeda Pharmaceutical on the launch of Amitiza in the US for another indication.
You may also be interested in...
Accessing Venture Debt From The EIB
Tips from Gergely Krajcsi, senior investment officer at the European Investment Bank, on how biotechs can access loans for faster growth.
In Vivo's 2024 Rising Leaders At A Glance
Top 30 leaders: see the list of industry influencers highlighted in the fifth edition of In Vivo's Rising Leaders series.
In Vivo’s 2024 Rising Leaders
The fifth annual listing of In Vivo’s Rising Leaders includes entrepreneurs and innovators from across the world who represent the next wave of creativity in health care.